Toronto, ON, & Vancouver, BC – June 17, 2026 – Medventions, founded at Sunnybrook Research Institute, is a healthcare-based, medtech innovation fellowship program that targets clinical needs and nurtures Canada’s rising medtech talent base. During the Medventions Toronto Innovation Day on June 9, Co-founder and Co-director, Dr. Ahmed Nasef, announced the launch of the Medventions Mitacs Umbrella agreement. This Umbrella will support Medventions fellowship programs across Canada, including in Ontario, Nova Scotia, and Newfoundland and Labrador over the next two years.
“The launch of the Medventions Mitacs Umbrella represents an important milestone in building a pan-Canadian health innovation talent pipeline and expanding experiential innovation training opportunities for the next generation of healthcare innovators."
Since 2021, Sunnybrook Research Institute and Mitacs have worked together to support interns within the Medventions programs. The Umbrella formalizes this partnership and expedites the process, so more medtech talent can be trained across Canada. The Umbrella will support 39 internships within the Medventions program, equipping the next generation of medtech entrepreneurs with invaluable hands-on experience and the skills they need to succeed.
"The most transformative breakthroughs in healthcare often happen at the intersection of rigorous research and real-world clinical insight. Mitacs’ partnership with Sunnybrook to bolster their Medventions program reflects a shared commitment to accelerating made-in-Canada medical innovations that address the health challenges of today and tomorrow. By removing barriers between researchers, clinicians, and industry, we are creating a direct pathway from innovation to impact for patients."
“The most transformative breakthroughs in healthcare often happen at the intersection of rigorous research and real-world clinical insight. Mitacs’ partnership with Sunnybrook to bolster their Medventions program reflects a shared commitment to accelerating made-in-Canada medical innovations that address the health challenges of today and tomorrow,” said Dr. Stephen Lucas, President and CEO of Mitacs. “By removing barriers between researchers, clinicians, and industry, we are creating a direct pathway from innovation to impact for patients.”
Medventions is supported by INOVAIT, Sunnybrook Research Institute, and the Strategic Response Fund through Innovation, Science, and Economic Development Canada.
